BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8162713)

  • 41. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IUDs: current perspectives.
    Hepburn S
    Curr Ther (Seaforth); 1994 Oct; 35(10):49-55. PubMed ID: 12319352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytologic picture of smears from the cervix uteri of women using intrauterine contraceptive devices (IUD)].
    Wagrowska-Danilewicz M; Gwóźdź AZ; Danilewicz M
    Ginekol Pol; 1988 Dec; 59(12):724-7. PubMed ID: 3254840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The intrauterine device and ectopic pregnancy.
    Edelman DA; Porter CW
    Contraception; 1987 Jul; 36(1):85-96. PubMed ID: 3311627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of intrauterine devices: biochemical changes.
    Johannisson E
    Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ectopic pregnancy and IUDs; incidence, risk rate and predisposing factors.
    Meirik O; Nygren KG
    Acta Obstet Gynecol Scand; 1980; 59(5):425-7. PubMed ID: 7446008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contraception after thirty-five.
    Luukkainen T
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):169-74. PubMed ID: 1317637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intrauterine devices].
    Delavest P; Engelmann P
    Rev Prat; 1980 Dec; 30(57):3981-2, 3985-7. PubMed ID: 7455547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
    Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
    Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A national study to monitor the safety of IUCD use.
    Richardson A; Paul C
    Contraception; 1993 Apr; 47(4):359-66. PubMed ID: 8508665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of the lost IUD.
    Otolorin EO
    Afr J Med Med Sci; 1985; 14(3-4):125-9. PubMed ID: 3004172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.